Neurology 2014-02 - Neurology Alert - Feb 01, 2014

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Physician Editor
Matthew Fink, MD
Interim Chair and Neurologist-in-Chief
Department of Neurology and Neuroscience
Weill Cornell Medical College
New York Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Anne Parrish Titzel Professor
Department of Neurology and Neuroscience
Weill Cornell Medical Center

Assistant Editors
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders
Weill Cornell Medical College

Claire Henchcliffe, MD, PhD
Associate Professor of Neurology and Neuroscience
Weill Cornell Medical College

Dara Jamieson, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College

Alan Z. Segal, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College

Authors
Elayna Rubens, MD
Assistant Professor of Neurology,
Weill Cornell Medical College

Claire Henchcliffe, MD
Associate Professor of Neurology and Neuroscience,
Weill Cornell Medical College
Matthew E. Fink, MD,
Professor and Chairman,
Department of Neurology,
Weill Cornell Medical College, and
Neurologist-in-Chief,
New York Presbyterian Hospital

Alexander Shtilbans, MD, PhD
Assistant Professor of Neurology,
Weill Cornell Medical College

Michael Rubin, MD
Professor of Clinical Neurology,
Weill Cornell Medical College

Subjects:

  • Efficacy of Continuous EEG Monitoring in Critical Care Units
  • Prolonged Release Oxycodone-Naloxone for Treatment of Severe RLS
  • Inhaled Apomorphine as a Rescue Treatment in Parkinson's Disease
  • Height and Bone Age in Treated Juvenile Myasthenia Gravis

Objectives:

  • Discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • Discuss the pathogenesis and treatment of pain
  • Describe the basic science of brain function
  • Discuss new information regarding new drugs for commonly diagnosed neurological conditions

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Authors Elayna Rubens, MD, Matthew E. Fink, MD, Alexander Shtilbans, MD, PhD and Michael Rubin, MD report no financial relationships relevant to this field of study.

Author Claire Henchcliffe, MD reports she is on the speakers bureau and advisory board for GE, Teva Pharmaceutical Industries, and UCB; advisory board for Allergan and USWorldmeds; receives grant/research support from Biogen and Kaneka; and does CME program development and presentation for MedIQ.

Copyright 2014, AHC Media. All rights reserved.